Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak
Launched by MEDIPOL UNIVERSITY · Apr 5, 2021
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
The aim of this study is to evaluate the process experienced by physiotherapists while providing rehabilitation services during the epidemic and to investigate the procedures adopted by physiotherapists who are currently working.
In addition, by analyzing the effects of both the pandemic and the clinical and educational organizations in the Physiotherapy and Rehabilitation Clinics where physiotherapists were working during the COVID-19 epidemic, the needs arising after the pandemic can be reported.
Assessments will be carried out by researcher physiotherapists through a questionnaire base...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.
- Exclusion Criteria:
- • Not meeting the inclusion criteria
About Medipol University
Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Beykoz, Turkey
Patients applied
Trial Officials
Gülay Aras Bayram, asAss. Prof.
Study Chair
Medipol University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials